Journal of Child and Adolescent Health

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Perspective - Journal of Child and Adolescent Health (2023) Volume 7, Issue 6

Navigating Adolescent Ischemic Priapism: A Medical Challenge

Tanden Rodge *

Department of Anesthesiology and Pain Medicine, University of Colorado Anschutz, United States.

*Corresponding Author:
Tanden Rodge
Department of Anesthesiology and Pain Medicine
University of Colorado Anschutz
United States

Received:03-Dec-2023,Manuscript No. AAJCAH-24-122886; Editor assigned:05-Dec-2023,PreQC No. AAJCAH-24-122886(PQ); Reviewed:19-Dec-2023,QC No. AAJCAH-24-122886; Revised:23-Dec-2023, Manuscript No. AAJCAH-24-1228846(R); Published:31-Dec-2023,DOI:10.35841/aajcah-7.6.184

Citation: Rodge T. Navigating adolescent ischemic priapism: A medical challenge. J Child Adolesc Health. 2023;7(6):184

Visit for more related articles at Journal of Child and Adolescent Health




Adolescence is a time of physical, emotional, and hormonal changes, and while many health concerns may be considered normal during this developmental stage, some conditions demand immediate attention and specialized care. Ischemic priapism, an uncommon but serious medical condition characterized by persistent and painful erections, can occur in adolescents, presenting unique challenges for both patients and healthcare providers [1,2].

Ischemic priapism is a condition in which blood becomes trapped in the erection chambers of the penis, leading to a prolonged and painful erection. While it is relatively rare in adolescents, the consequences of untreated ischemic priapism can be severe, potentially resulting in permanent damage to erectile tissue and long-term sexual dysfunction. Unlike the more common form of priapism, known as non-ischemic or high-flow priapism, ischemic priapism requires urgent medical attention. In ischemic priapism, blood flow becomes restricted, leading to oxygen deprivation in the erectile tissues. This lack of oxygen can cause irreversible damage and necessitates swift intervention to prevent long-term complications [3,4].

Adolescents experiencing ischemic priapism often face a delicate balance between the physical discomfort of the condition and the potential embarrassment or stigma associated with discussing such intimate health matters. For healthcare providers, recognizing the urgency of the situation and approaching the adolescent with empathy and sensitivity becomes crucial in providing effective and timely care [5,6].

The causes of ischemic priapism in adolescents can vary, with some cases attributed to underlying medical conditions, such as sickle cell disease, leukemia, or certain medications. Trauma to the genital area, such as a sports injury, may also trigger ischemic priapism. Understanding the root cause is paramount in determining the appropriate course of treatment and preventing recurrent episodes. Managing ischemic priapism in adolescents typically involves the aspiration and irrigation of blood from the penis, a procedure aimed at relieving the trapped blood and restoring normal blood flow. In some cases, medications may be administered to help constrict blood vessels and reduce inflammation. Timely intervention is crucial, as prolonged episodes increase the risk of irreversible damage. While the physical aspect of ischemic priapism demands immediate attention, addressing the emotional and psychological well-being of adolescents is equally important. Open communication between healthcare providers, patients, and their families is essential in navigating the sensitive nature of this condition. Ensuring that adolescents feel heard, respected, and supported throughout the diagnostic and treatment process is vital for their overall well-being [7,8].

Ischemic priapism in adolescents poses a unique set of challenges that require prompt and specialized medical attention. Beyond the physical discomfort associated with persistent and painful erections, adolescents dealing with this condition may also face emotional and psychological hurdles. Healthcare providers play a critical role not only in diagnosing and treating ischemic priapism but also in fostering a supportive environment that acknowledges the sensitivity of this intimate health concern. Recognizing the urgency of ischemic priapism and addressing the root causes are paramount in preventing long-term complications and preserving sexual function. The collaboration between healthcare providers, adolescents, and their families is crucial in navigating the delicate balance between medical intervention and emotional support [9,10].


In the realm of adolescent health, ischemic priapism stands as a reminder that even uncommon conditions can have a profound impact on the well-being of young individuals. Through awareness, early intervention, and compassionate care, we can work towards ensuring that adolescents facing ischemic priapism receive the medical attention and support they need to navigate this challenging aspect of their health and well-being.



  1. Anele UA, Burnett AL. Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: Profile and risk factors. J Sex Med. 2015;12:713–9.
  2. Indexed at, Google Scholar, Cross Ref

  3. Aabbassi B. Risperidone-induced priapism in an autistic child: A case report. J Med Case Rep. 2016;10:164.
  4. Indexed at, Google Scholar, Cross Ref

  5. Burnett AL. Randomized controlled trial of sildenafil for preventing recurrent ischemic priapism in sickle cell disease. Am J Med. 2014;127:664–8.
  6. Indexed at, Google Scholar, Cross Ref

  7. Zheng D. Unsatisfactory outcomes of prolonged ischemic priapism without early surgical shunts: our clinical experience and a review of the literature. Asian J Androl. 2013;15: 75–78.
  8. Indexed at, Google Scholar, Cross Ref

  9. Wen J. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. FASEB J. 2010; 24: 740–749.
  10. Indexed at, Google Scholar, Cross Ref

  11. Nolan V. Hemolysis-associated priapism in sickle cell disease. Blood. 2005; 106: 3264–3267.
  12. Indexed at, Google Scholar, Cross Ref

  13. Mi T. Excess adenosine in murine penile erectile tissues contributes to priapism via A2B adenosine receptor signaling. J Clin Invest. 2008; 118: 1491–1501.
  14. Indexed at, Google Scholar, Cross Ref

  15. Levey HR. Medical management of ischemic stuttering priapism: a contemporary review of the literature. Asian J Androl. 2012; 14: 156–163.
  16. Indexed at, Google Scholar, Cross Ref

  17. Kato G. Endogenous nitric oxide synthase inhibitors in sickle cell disease: abnormal levels and correlations with pulmonary hypertension, desaturation, haemolysis, organ dysfunction and death. Br J Haematol. 2009;145: 506–513.
  18. Indexed at, Google Scholar, Cross Ref

  19. Hannan J. Inhibition of Rho-kinase improves erectile function, increases nitric oxide signaling and decreases penile apoptosis in a rat model of cavernous nerve injury. J Urol. 2013; 189: 1155–1161.
  20. Indexed at, Google Scholar, Cross Ref

Get the App